Bayer Aktiengesellschaft (WSE:BAY)
198.18
0.00 (0.00%)
Feb 12, 2026, 11:30 AM CET
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of 189.23 billion as of February 12, 2026. Its market cap has increased by 109.80% in one year.
Market Cap
189.23B
Enterprise Value
326.31B
Revenue
195.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
198.18
Market Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 13.77B to 189.23B, an increase of 1,274.11%. That is a compound annual growth rate of 7.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 190.96B | 24.41% |
| Dec 30, 2025 | 153.49B | 89.32% |
| Dec 30, 2024 | 81.08B | -43.53% |
| Dec 29, 2023 | 143.58B | -35.37% |
| Dec 30, 2022 | 222.16B | 4.87% |
| Dec 30, 2021 | 211.85B | -2.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.08B |
| NEUCA | 3.51B |
| Synektik Spólka Akcyjna | 2.54B |
| Voxel | 1.44B |
| Celon Pharma | 1.27B |
| Selvita | 816.82M |
| Centrum Medyczne ENEL-MED | 616.51M |
| Ryvu Therapeutics | 578.00M |